Skip to main content
. 2017 Mar 1;19(3):164–172. doi: 10.1089/dia.2016.0392

Table 2.

Demographics and Baseline Characteristics (Intention-to-Treat Population)

Variable ITT (n = 50)
Age 47.2 (15.7)
  50.0 (19.0; 77.0)
  n = 50
Sex
 Male 30 (60.0%)
 Female 20 (40.0%)
Diabetes duration 21.4 (13.1)
  16.8 (1.1; 60.7)
  n = 50
BMI (kg/m2) 25.5 (4.2)
  24.7 (19.3; 35.9)
  n = 49
Smoking 8 (16.0%)
HbA1c (%, NGSP) 8.18 (1.40)
  8.10 (5.54; 12.58)
  n = 50
A/C ratio 2.02 (4.09)
  0.90 (0.20; 20.90)
  n = 43
Insulin delivery
 CSII 13 (26.0%)
 MDI 37 (74.0%)
Insulin dose 47.8 (25.0)
  40.0 (15.0; 136.0)
  n = 50
Systolic blood pressure 128.7 (14.6)
  128.0 (104.0; 166.0)
  n = 49
Diastolic blood pressure 71.4 (9.3)
  72.0 (43.0; 93.0)
  n = 49
Average number of hypoglycemia per month 6.64 (6.99)
  4.00 (0.00; 30.00)
  n = 50
Previous myocardial infarction 0 (0.0%)
Previous stroke 1 (2.0%)
Previous amputation 1 (2.0%)
Previous foot ulcers 0 (0.0%)
Current foot ulcers 4 (8.0%)
Previous retinopathy 3 (6.0%)

For categorical variables n (%) is presented.

For continuous variables mean (SD)/median (Min; Max)/n is presented.

A/C, albumin/creatinine; CSII, continuous subcutaneous insulin infusion; HbA1c, hemoglobin A1c; ITT, intention-to-treat; MDI, multiple daily insulin injections; NGSP, National Glycohemoglobin Standardization Program.